The U.S. Food and Drug Administration and the Federal Trade Commission today posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal.
- For More Information
|Company Name||Product Name and Image|
TaperAid and TaperAid Complete
1 Product name linked to Flickr image when available.